Table 1.
Ligand | References |
---|---|
Endogenous | |
SCARF1 | [5] |
SCARF2 | [5] |
Modified low-density lipoproteins (oxLDLs and AcLDLs) | [4] |
Apoptotic cells (via complement factor C1q) | [8] |
Heat shock proteins (Hsp70, Hsp90, Hsp110) | [11, 17–19] |
Calreticulin | [20] |
Tamm–Horsfall protein | [21] |
Pancreatic zymogen granule protein 2 (GP2) | [22] |
Protein phosphatase 1α CD4+ T cells (unknown ligand) |
[23] [10] |
Exogenous | |
Bacterial antigens | |
Teichoic acid (S. aureus) | [12] |
Lipopolysaccharide (LPS) | [10, 24] |
Outer membrane protein (Omp)A (K. pneumoniae) | [25] |
Porin (Por)BIA (N. gonorrhoeae; via Gp96) | [13] |
Viral antigens | |
Non-structural protein (NS)3 (Hepatitis C virus; HCV) | [26] |
dsRNA | [27] |
Fungal antigens | |
β-Glucan (C. albicans and C. neoformans) | [6] |
A number of endogenous and exogenous ligands have been described in the literature to date and are listed above
S. aureus: Staphylococcus aureus, K. pneumonia: Klebsiella pneumonia, N. gonorrhoeae: Neisseria gonorrhoeae, C. albicans: Candida albicans, C. neoformans: Cryptococcus neoformans